These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 9851770
1. Growth hormone secretagogue receptor expression in human pituitary tumors. Skinner MM, Nass R, Lopes B, Laws ER, Thorner MO. J Clin Endocrinol Metab; 1998 Dec; 83(12):4314-20. PubMed ID: 9851770 [Abstract] [Full Text] [Related]
2. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M, Jacobs RA, Aylwin SJ, Burrin JM, Dahia PL, Monson JP, Honegger J, Fahlbush R, Trainer PJ, Chew SL, Besser GM, Grossman AB. J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [Abstract] [Full Text] [Related]
3. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies. Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A. J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306 [Abstract] [Full Text] [Related]
4. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T. Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110 [Abstract] [Full Text] [Related]
5. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB. J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061 [Abstract] [Full Text] [Related]
7. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas. Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM, Ferrier R, Jones TH, Baldeweg S, Powell M, Czirják S, Hanzély Z, Johansson JO, Korbonits M, Grossman AB. J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214 [Abstract] [Full Text] [Related]
8. High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. Nass R, Gilrain J, Anderson S, Gaylinn B, Dalkin A, Day R, Peruggia M, Thorner MO. Endocrinology; 2000 Jun; 141(6):2084-9. PubMed ID: 10830294 [Abstract] [Full Text] [Related]
10. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells. Adams EF, Huang B, Buchfelder M, Howard A, Smith RG, Feighner SD, van der Ploeg LH, Bowers CY, Fahlbusch R. J Clin Endocrinol Metab; 1998 Feb; 83(2):638-42. PubMed ID: 9467586 [Abstract] [Full Text] [Related]
11. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein. Kim K, Sanno N, Arai K, Takano K, Yasufuku-Takano J, Teramoto A, Shibasaki T. Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888 [Abstract] [Full Text] [Related]
12. Gene transcription of receptors for growth hormone-releasing peptide and somatostatin in human pituitary adenomas. Nielsen S, Mellemkjaer S, Rasmussen LM, Ledet T, Astrup J, Weeke J, Jørgensen JO. J Clin Endocrinol Metab; 1998 Aug; 83(8):2997-3000. PubMed ID: 9709982 [Abstract] [Full Text] [Related]
13. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Peng XD, Park S, Gadelha MR, Coschigano KT, Kopchick JJ, Frohman LA, Kineman RD. Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526 [Abstract] [Full Text] [Related]
14. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610 [Abstract] [Full Text] [Related]
16. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas. Kim K, Arai K, Sanno N, Teramoto A, Shibasaki T. Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082 [Abstract] [Full Text] [Related]
17. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors. Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA. Thyroid; 1998 Jan; 8(1):9-14. PubMed ID: 9492147 [Abstract] [Full Text] [Related]
18. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. Volante M, Allìa E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E, Papotti M. J Clin Endocrinol Metab; 2002 Mar; 87(3):1300-8. PubMed ID: 11889202 [Abstract] [Full Text] [Related]
19. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J. J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505 [Abstract] [Full Text] [Related]
20. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland. Ueberberg B, Unger N, Sheu SY, Walz MK, Schmid KW, Saeger W, Mann K, Petersenn S. Horm Metab Res; 2008 Mar; 40(3):181-8. PubMed ID: 18246525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]